Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MNPR | AMGN | BMY | GILD | ILMN |
| Company | Monopar Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.6600 | 269.84 | 49.00 | 66.93 | 118.58 |
| High | 0.6600 | 273.14 | 49.56 | 67.57 | 120.99 |
| Low | 0.6200 | 269.84 | 48.87 | 66.74 | 117.48 |
| Last | 0.6320 | 271.91 | 49.14 | 66.95 | 120.25 |
| Change | -0.0081 | +2.98 | +0.21 | +0.19 | +2.82 |
| % Change | -1.27% | +1.11% | +0.43% | +0.28% | +2.40% |
| Volume | 27,700 | 2,165,700 | 7,929,500 | 5,622,300 | 1,151,100 |
| 20-Day Average Volume | 182,980 | 2,239,560 | 11,113,590 | 6,350,505 | 1,492,310 |
| Previous Close | 0.6401 | 268.93 | 48.93 | 66.76 | 117.43 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6768 | 272.35 | 50.71 | 69.61 | 127.54 |
| 20-Day Raw Stochastic | 37.73% | 40.27% | 22.23% | 13.17% | 18.57% |
| 20-Day Relative Strength | 46.87% | 47.06% | 42.35% | 32.36% | 40.14% |
| Weighted Alpha | -80.95 | +10.54 | -25.43 | -20.99 | -39.11 |
| Today's Opinion | 24% Buy | 40% Sell | 88% Sell | 100% Sell | 72% Sell |
| Previous Opinion | 24% Buy | 56% Sell | 72% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 72% Buy | 8% Buy | 24% Sell | 88% Sell | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.29% since 04/15/24 | +2.41% since 04/15/24 | +1.30% since 04/15/24 | -1.18% since 04/15/24 | -0.75% since 04/15/24 |
| Low | 0.6200 on 04/22/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 0.7403 on 04/16/24 | 273.14 on 04/22/24 | 49.56 on 04/22/24 | 67.89 on 04/16/24 | 120.99 on 04/22/24 |
| 1-Month | |||||
| %Chg | -8.35% since 03/22/24 | -1.54% since 03/22/24 | -5.37% since 03/22/24 | -7.80% since 03/22/24 | -12.38% since 03/22/24 |
| Low | 0.4999 on 04/10/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 0.8500 on 04/11/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +78.53% since 01/22/24 | -12.33% since 01/22/24 | -0.87% since 01/22/24 | -14.64% since 01/22/24 | -13.41% since 01/22/24 |
| Low | 0.3090 on 02/07/24 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 1.7300 on 02/23/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +38.54% since 10/20/23 | -2.47% since 10/20/23 | -12.96% since 10/20/23 | -13.95% since 10/20/23 | +0.51% since 10/20/23 |
| Low | 0.2739 on 11/27/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 1.7300 on 02/23/24 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,032 | 145,845,984 | 99,594,944 | 83,357,904 | 19,150,414 |
| Shares Outstanding, K | 17,455 | 536,376 | 2,026,759 | 1,245,077 | 159,255 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -8,400,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -1,810,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 1.19 | 0.58 | 0.39 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 03/28/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 6.52 | 9.93 | 134.98 |